Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$42.05 - $47.77 $210,460 - $239,088
-5,005 Closed
0 $0
Q1 2022

May 06, 2022

BUY
$40.23 - $47.74 $201,351 - $238,938
5,005 New
5,005 $218,000
Q4 2020

Feb 03, 2021

SELL
$34.07 - $39.94 $4.2 Million - $4.92 Million
-123,192 Closed
0 $0
Q3 2020

Nov 05, 2020

SELL
$38.11 - $42.99 $1.23 Million - $1.38 Million
-32,202 Reduced 20.72%
123,192 $4.61 Million
Q2 2020

Jul 28, 2020

SELL
$37.87 - $43.58 $931,223 - $1.07 Million
-24,590 Reduced 13.66%
155,394 $6.31 Million
Q1 2020

Apr 30, 2020

SELL
$32.47 - $48.83 $123,970 - $186,432
-3,818 Reduced 2.08%
179,984 $6.79 Million
Q4 2019

Feb 14, 2020

SELL
$42.0 - $48.25 $216,510 - $248,728
-5,155 Reduced 2.73%
183,802 $8.61 Million
Q3 2019

Oct 30, 2019

SELL
$40.46 - $43.52 $1.01 Million - $1.08 Million
-24,909 Reduced 11.65%
188,957 $8.04 Million
Q2 2019

Aug 05, 2019

SELL
$39.4 - $42.7 $726,102 - $786,918
-18,429 Reduced 7.93%
213,866 $8.54 Million
Q1 2019

May 06, 2019

BUY
$38.57 - $42.69 $5.81 Million - $6.43 Million
150,545 Added 184.15%
232,295 $9.68 Million
Q4 2018

Feb 12, 2019

SELL
$37.8 - $42.69 $3.23 Million - $3.65 Million
-85,529 Reduced 51.13%
81,750 $3.1 Million
Q3 2018

Nov 02, 2018

SELL
$39.75 - $42.69 $304,087 - $326,578
-7,650 Reduced 4.37%
167,279 $6.7 Million
Q2 2018

Aug 09, 2018

SELL
$39.61 - $42.76 $350,944 - $378,853
-8,860 Reduced 4.82%
174,929 $7.03 Million
Q1 2018

Apr 30, 2018

BUY
$36.18 - $40.15 $3.22 Million - $3.58 Million
89,049 Added 93.99%
183,789 $7.16 Million
Q4 2017

Feb 02, 2018

SELL
$35.34 - $41.9 $1.12 Million - $1.33 Million
-31,750 Reduced 25.1%
94,740 $3.35 Million
Q3 2017

Nov 06, 2017

BUY
$39.44 - $41.55 $4.99 Million - $5.26 Million
126,490
126,490 $5.12 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.4B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.